David Bredt, the Chief Scientific Officer of $RAPP, sold 8,500 shares of the company on 07-15-2025 for an estimated $118,961. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of their shares of this class of stock. Following this trade, they now own 435,142 shares of this class of $RAPP stock.
$RAPP Insider Trading Activity
$RAPP insiders have traded $RAPP stock on the open market 8 times in the past 6 months. Of those trades, 3 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $RAPP stock by insiders over the last 6 months:
- DAVID BREDT (Chief Scientific Officer) has made 0 purchases and 5 sales selling 42,500 shares for an estimated $467,261.
- TROY A. IGNELZI (Chief Financial Officer) has made 2 purchases buying 10,000 shares for an estimated $100,988 and 0 sales.
- WENDY B. YOUNG purchased 6,000 shares for an estimated $61,249
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RAPP Analyst Ratings
Wall Street analysts have issued reports on $RAPP in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JMP Securities issued a "Market Outperform" rating on 04/08/2025
To track analyst ratings and price targets for $RAPP, check out Quiver Quantitative's $RAPP forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
